The product is a lyophilized growth supplement for use with dehydrated culture media to prepare BCYE Medium used for isolation of Legionellae from clinical and environmental samples.
Published February 20, 2013 · Recall initiated: October 10, 2012
Summary
FDA records medical device Class II recall Z-0801-2013, published February 20, 2013 and initiated October 10, 2012. Recalling firm: Remel Inc; Status: Terminated; Reported quantity: 10 units; Lot: Lot 1175209. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The product may contain low level microbial contamination which could result in incorrect results.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Remel Inc
- Distributor
- Distribution included the states of IL, IN and MI.
- Lot
- Lot 1175209
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAThermo SCIENTIFIC, Sensititre STP6F, Gram Negative IVD ASTDecember 14, 2022
- FDAThio Med w/Dex, Hem, Vit K (5ml) 100/PK Product Usage; Recommended for use in qualitative procedures as aMay 29, 2019
- FDAThio Med w/Dex, Hemin, Vit K (5ml) 20/PK Product Usage: Recommended for use in qualitative procedures as aMay 29, 2019
- FDABlood Agar (TSA w/ 5% Sheep Blood) Plate, For In Vitro Diagnostic Use, Remel, Lenexa, KS 66215 Product Usage:May 3, 2017
- FDABacterin International, Inc., Osteoselect Demineralized Bone Matrix DMB Putty; Graft ID# B090056-664 Donor#February 20, 2013
- FDATerumo CDI 101 Hematocrit/Oxygen Saturation Monitoring System. Monitors blood/oxygen saturation, hematocritFebruary 20, 2013
Questions about this recall
Was The product is a lyophilized growth supplement for use with dehydrated culture media to prepare BCYE Medium used for isolation of Legionellae from clinical and environmental samples. recalled?
Yes. FDA published recall Z-0801-2013 on February 20, 2013. Reported hazard: The product may contain low level microbial contamination which could result in incorrect results.
What should I do if I have this product?
Voluntary: Firm initiated · Letter